QIAGEN NV EO -,01 | 44.770 / -0.33% |
Date/Time | 01/20 / 17:35 |
Chg. / Chg.(%) | -0.150 / -0.33% |
Bid | - |
Ask | - |
Open | 44.760 |
Previous Close | 44.920 |
High | 45.090 |
Low | 44.630 |
Volume [EUR] | 13,740,943.610 |
Volume [Units] | 306,470 |
Price fixings | 1428 |
ISIN | NL0012169213 |
Security | QIA |
Exchange | Xetra |
Type | Stock |
Exchange | Last | Volume | |
---|---|---|---|
Turquoise | 44.89 | ![]() |
456,318 |
NYSE | 53.87 | ![]() |
309,647 |
Xetra | 44.770 | ![]() |
306,470 |
Cboe Europe .. | 44.88 | ![]() |
147,780 |
London Inter.. | 44.94 | ![]() |
119,048 |
TradeGate | 44.58 | ![]() |
10,978 |
Frankfurt | 44.7800 | ![]() |
10,593 |
IEX | 53.90 | ![]() |
10,261 |
Cboe US | 53.90 | ![]() |
9,894 |
Cboe Europe .. | 44.99 | ![]() |
1,777 |
Stuttgart | 44.410 | ![]() |
322 |
Cboe Europe .. | 44.91 | ![]() |
252 |
gettex | 44.620 | ![]() |
134 |
Hannover | 44.790 | ![]() |
2 |
Vienna Globa.. | 44.87 | ![]() |
0 |
München | 44.720 | ![]() |
0 |
Düsseldorf | 44.480 | ![]() |
0 |
Hamburg | 44.730 | ![]() |
0 |
Berlin | 44.720 | ![]() |
0 |
Lang & Schwa.. | 44.400 | ![]() |
|
EUREX | Options |
News
- OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12/09/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
11/10/2020 / 22:01 - GlobeNewswire - Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
10/06/2020 / 21:30 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
08/13/2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
08/11/2020 / 22:01 - GlobeNewswire